1. Butyrylcholinesterase as a Blood Biomarker in Neuroblastoma. Issue 4 (May 2017) Authors: Coulter, Don W.; Boettner, Angela D.; Kortylewicz, Zbigniew P.; Enke, Stephen P.; Luther, Jake A.; Verma, Vivek; Baranowska-Kortylewicz, Janina Journal: Journal of pediatric hematology/oncology Issue: Volume 39:Issue 4(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune checkpoint molecules in neuroblastoma: A clinical perspective. (November 2022) Authors: Pathania, Anup S.; Prathipati, Philip; Murakonda, Swati P.; Murakonda, Ajay B.; Srivastava, Ankit; Avadhesh, ; Byrareddy, Siddappa N.; Coulter, Don W.; Gupta, Subash C.; Challagundla, Kishore B. Journal: Seminars in cancer biology Issue: Volume 86(2023)Part 2 Page Start: 247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. MiR‐15a‐5p, miR‐15b‐5p, and miR‐16‐5p inhibit tumor progression by directly targeting MYCN in neuroblastoma. Issue 1 (29th November 2019) Authors: Chava, Srinivas; Reynolds, C. Patrick; Pathania, Anup S.; Gorantla, Santhi; Poluektova, Larisa Y.; Coulter, Don W.; Gupta, Subash C.; Pandey, Manoj K.; Challagundla, Kishore B. Journal: Molecular oncology Issue: Volume 14:Issue 1(2020) Page Start: 180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. PD-L1, inflammation, non-coding RNAs, and neuroblastoma: Immuno-oncology perspective. (October 2018) Authors: Nallasamy, Palanisamy; Chava, Srinivas; Verma, Sumit S.; Mishra, Shruti; Gorantla, Santhi; Coulter, Don W.; Byrareddy, Siddappa N.; Batra, Surinder K.; Gupta, Subash C.; Challagundla, Kishore B. Journal: Seminars in cancer biology Issue: Volume 52(2018)Part 2 Page Start: 53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Radiolabeled (R)‐(–)‐5‐iodo‐3′‐O‐[2‐(ε‐guanidinohexanoyl)‐2‐phenylacetyl]‐2′‐deoxyuridine: A new theranostic for neuroblastoma. (19th March 2020) Authors: Kortylewicz, Zbigniew P.; Coulter, Don W.; Han, Guang; Baranowska‐Kortylewicz, Janina Journal: Journal of labelled compounds & radiopharmaceuticals Issue: Volume 63:Number 7(2020) Page Start: 312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Refractory autoimmune hemolytic anemia after intestinal transplant responding to conversion from a calcineurin to mTOR inhibitor. (3rd June 2013) Authors: Acquazzino, Melissa A.; Fischer, Ryan T.; Langnas, Alan; Coulter, Don W. Journal: Pediatric transplantation Issue: Volume 17:Number 5(2013:Aug.) Page Start: 466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Suppression of STAT3 NH2‐terminal domain chemosensitizes medulloblastoma cells by activation of protein inhibitor of activated STAT3 via de‐repression by microRNA‐21. Issue 4 (25th January 2018) Authors: Ray, Sutapa; Coulter, Don W.; Gray, Shawn D.; Sughroue, Jason A.; Roychoudhury, Shrabasti; McIntyre, Erin M.; Chaturvedi, Nagendra K.; Bhakat, Kishor K.; Joshi, Shantaram S.; McGuire, Timothy R.; Sharp, John G. Journal: Molecular carcinogenesis Issue: Volume 57:Issue 4(2018) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. The emerging role of non-coding RNAs in the epigenetic regulation of pediatric cancers. (August 2022) Authors: Pathania, Anup S.; Prathipati, Philip; Pandey, Manoj K.; Byrareddy, Siddappa N.; Coulter, Don W.; Gupta, Subash C.; Challagundla, Kishore B. Journal: Seminars in cancer biology Issue: Volume 83(2022) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗